Increased bone formation in mice lacking plasminogen activators

被引:65
作者
Daci, E
Everts, V
Torrekens, S
Van Herck, E
Tigchelaar-Gutterr, W
Bouillon, R
Carmeliet, G
机构
[1] Catholic Univ Louvain, Lab Expt Med & Endocrinol, Louvain, Belgium
[2] Univ Amsterdam, Acad Med Ctr, Dept Cell Biol & Histol, NL-1105 AZ Amsterdam, Netherlands
[3] Univ Amsterdam, Acad Med Ctr, Dept Periodontol, NL-1105 AZ Amsterdam, Netherlands
关键词
plasminogen activators; mice; osteoblast; matrix degradation; bone formation;
D O I
10.1359/jbmr.2003.18.7.1167
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Plasminogen activators tPA and uPA are involved in tissue remodeling, but their role in bone growth is undefined. Mice lacking tPA and uPA show increased bone formation and bone mass. The noncollagenous components of bone matrix are also increased, probably from defective degradation. This study underlines the importance of controlled bone matrix remodeling for normal endochondral ossification. Introduction: Proteolytic pathways are suggested to play a role in endochondral ossification. To elucidate the involvement of the plasminogen activators tPA and uPA in this process, we characterized the long bone phenotype in mice deficient in both tPA and uPA (tPA(-/-):uPA(-/-)). Materials and Methods: Bones of 2- to 7-day-old tPA(-/-):uPA(-/-) and wild-type (WT) mice were studied using bone histomorphometry, electron microscopy analysis, and biochemical assessment of bone matrix components. Cell-mediated degradation of metabolically labeled bone matrix, osteoblast proliferation, and osteoblast differentiation, both at the gene and protein level, were studied in vitro using cells derived from both genotypes. Results: Deficiency of the plasminogen activators led to elongation of the bones and to increased bone mass (25% more trabecular bone in the proximal tibial metaphysis), without altering the morphology of the growth plate. In addition, the composition of bone matrix was modified in plasminogen activator deficient mice, because an increased amount of proteoglycans (2X), osteocalcin (+45%), and fibronectin (+36%) was detected. Matrix degradation assays showed that plasminogen activators, by generating plasmin, participate in osteoblast-mediated degradation of the noncollagenous components of bone matrix. In addition, proliferation of primary osteoblasts derived from plasminogen activator-deficient mice was increased by 35%. Finally, osteoblast differentiation and formation of a mineralized bone matrix were enhanced in osteoblast cultures derived from tPA(-/-):uPA(-/-) mice. Conclusions: The data presented indicate the importance of the plasminogen system in degradation of the noncollagenous components of bone matrix and suggest that the accumulation of these proteins in bone matrix-as occurs during plasminogen activator deficiency-may in turn stimulate osteoblast function, resulting in increased bone formation.
引用
收藏
页码:1167 / 1176
页数:10
相关论文
共 49 条
[1]
PROSTAGLANDIN E(2) REGULATES PRODUCTION OF PLASMINOGEN-ACTIVATOR ISOENZYMES, UROKINASE RECEPTOR, AND PLASMINOGEN-ACTIVATOR INHIBITOR-1 IN PRIMARY CULTURES OF RAT CALVARIAL OSTEOBLASTS [J].
ALLAN, EH ;
MARTIN, TJ .
JOURNAL OF CELLULAR PHYSIOLOGY, 1995, 165 (03) :521-529
[2]
TRANSFORMING GROWTH-FACTOR-BETA INHIBITS PLASMINOGEN-ACTIVATOR (PA) ACTIVITY AND STIMULATES PRODUCTION OF UROKINASE-TYPE PA, PA INHIBITOR-1 MESSENGER-RNA, AND PROTEIN IN RAT OSTEOBLAST-LIKE CELLS [J].
ALLAN, EH ;
ZEHEB, R ;
GELEHRTER, TD ;
HEATON, JH ;
FUKUMOTO, S ;
YEE, JA ;
MARTIN, TJ .
JOURNAL OF CELLULAR PHYSIOLOGY, 1991, 149 (01) :34-43
[3]
Fourier transform infrared microspectroscopic analysis of bones of osteocalcin-deficient mice provides insight into the function of osteocalcin [J].
Boskey, AL ;
Gadaleta, S ;
Gundberg, C ;
Doty, SB ;
Ducy, P ;
Karsenty, G .
BONE, 1998, 23 (03) :187-196
[4]
Boskey AL, 1999, DYNAMICS BONE CARTIL, P153
[5]
BOUILLON R, 1992, CLIN CHEM, V38, P2055
[6]
INVOLVEMENT OF THE PLASMIN SYSTEM IN DISSOCIATION OF THE INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN COMPLEX [J].
CAMPBELL, PG ;
NOVAK, JF ;
YANOSICK, TB ;
MCMASTER, JH .
ENDOCRINOLOGY, 1992, 130 (03) :1401-1412
[7]
Development and disease in proteinase-deficient mice: Role of the plasminogen, matrix metalloproteinase and coagulation system [J].
Carmeliet, P ;
Collen, D .
THROMBOSIS RESEARCH, 1998, 91 (06) :255-285
[8]
PHYSIOLOGICAL CONSEQUENCES OF LOSS OF PLASMINOGEN-ACTIVATOR GENE-FUNCTION IN MICE [J].
CARMELIET, P ;
SCHOONJANS, L ;
KIECKENS, L ;
REAM, B ;
DEGEN, J ;
BRONSON, R ;
DEVOS, R ;
VANDENOORD, JJ ;
COLLEN, D ;
MULLIGAN, RC .
NATURE, 1994, 368 (6470) :419-424
[9]
Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation [J].
Carmeliet, P ;
Moons, L ;
Lijnen, HR ;
Baes, M ;
Lemaitre, V ;
Tipping, P ;
Drew, A ;
Eeckhout, Y ;
Shapiro, S ;
Lupu, F ;
Collen, D .
NATURE GENETICS, 1997, 17 (04) :439-444
[10]
GENE TARGETING AND GENE-TRANSFER STUDIES OF THE PLASMINOGEN/PLASMIN SYSTEM - IMPLICATIONS IN THROMBOSIS, HEMOSTASIS, NEOINTIMA FORMATION, AND ATHEROSCLEROSIS [J].
CARMELIET, P ;
COLLEN, D .
FASEB JOURNAL, 1995, 9 (10) :934-938